ネオアジュバント化学療法、NAC
WordNet
- the use of chemical agents to treat or control disease (or mental illness)
PrepTutorEJDIC
- 化学療法
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/07/10 17:25:27」(JST)
[Wiki en表示]
Neoadjuvant therapy |
Intervention |
MeSH |
D020360 |
|
This article has multiple issues. Please help improve it or discuss these issues on the talk page. |
|
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (August 2012) |
|
This article needs more medical references for verification or relies too heavily on primary sources. Please review the contents of the article and add the appropriate references if you can. Unsourced or poorly sourced material may be removed. (July 2011) |
|
|
This article possibly contains original research. Please improve it by verifying the claims made and adding inline citations. Statements consisting only of original research should be removed. (July 2011) |
|
|
Neoadjuvant therapy is the administration of therapeutic agents before a main treatment. One example is neoadjuvant hormone therapy prior to radical radiotherapy for adenocarcinoma of the prostate. Neoadjuvant therapy aims to reduce the size or extent of the cancer before using radical treatment intervention, thus making procedures easier and more likely to succeed, and reducing the consequences of a more extensive treatment technique that would be required if the tumor wasn't reduced in size or extent.
Another related concept is that neoadjuvant therapy acts on micrometastatic disease. The downstaging is then a surrogate marker of efficacy on undetected dissemination, resulting in improved longtime survival compared to the surgery-alone strategy.[citation needed]
This systemic therapy (chemotherapy, immunotherapy or hormone therapy) or radiation therapy is commonly used in cancers that are locally advanced - where clinicians plan an operation at a later stage. The use of such therapy can effectively reduce the difficulty and morbidity of more extensive procedures.
The use of therapy can turn a tumour from untreatable to treatable by shrinking the volume. Often it can be unclear which surrounding structures are directly involved in the disease and which are just showing signs of inflammation. By administering therapy a distinction can often be made. Some doctors give the therapy in the hope that a response will be seen so that they can then decide what is the best course of action. Unfortunately, not everyone is suitable for therapy in this way because it can be extremely toxic. Some patients react so severely that further treatments, especially surgery, are precluded because the patient is rendered unfit for anesthetic.
See also
References
Adjuvant and Neoadjuvant Therapy for Breast Cancer (as defined by the US National Institutes of Health (NIH)[1])
Further reading
- Valentini, Vincenzo; Coco, Claudio; Picciocchi, Aurelio; Morganti, Alessio G; Trodella, Lucio; Ciabattoni, Antonella; Cellini, Francesco; Barbaro, Brunella et al. (2002). "Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients". International Journal of Radiation Oncology • Biology • Physics 53 (3): 664–74. doi:10.1016/S0360-3016(02)02764-5. PMID 12062610.
- Tollefson, Matthew K.; Boorjian, Stephen A.; Farmer, Sara A.; Frank, Igor (2012). "Downstaging to non-invasive urothelial carcinoma is associated with improved outcome following radical cystectomy for patients with cT2 disease". World Journal of Urology 30 (6): 795–9. doi:10.1007/s00345-012-0855-8. PMID 22447397.
- Rosenblatt, Robert; Sherif, Amir; Rintala, Erkki; Wahlqvist, Rolf; Ullén, Anders; Nilsson, Sten; Malmström, Per-Uno; Nordic Urothelial Cancer Group (2012). "Pathologic Downstaging is a Surrogate Marker for Efficacy and Increased Survival Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Urothelial Bladder Cancer". European Urology 61 (6): 1229–38. doi:10.1016/j.eururo.2011.12.010. PMID 22189383.
- ^ National Institutes of Health (NIH)
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Activity and resistance of trastuzumab according to different clinical settings.
- Tagliabue E, Campiglio M, Pupa SM, Ménard S, Balsari A.SourceMolecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy.
- Cancer treatment reviews.Cancer Treat Rev.2012 May;38(3):212-7. Epub 2011 Jul 2.
- Trastuzumab, a humanized monoclonal antibody directed against HER2, has shown efficacy in breast cancers; however many patients do not respond to this reagent. Here, we discuss the potential mechanisms of trastuzumab efficacy and resistance in different clinical settings as a step toward optimizing
- PMID 21726959
- 11C-Acetate PET/CT in Bladder Urothelial Carcinoma: Intraindividual Comparison With 11C-Choline.
- Orevi M, Klein M, Mishani E, Chisin R, Freedman N, Gofrit ON.SourceFrom the *Department of Nuclear Medicine and Medical Biophysics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; †Cyclotron Unit, Department of Nuclear Medicine and Medical Biophysics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; and ‡Department of Urology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
- Clinical nuclear medicine.Clin Nucl Med.2012 Apr;37(4):e67-72.
- OBJECTIVE: : We present a first study of the use of C-acetate (ACET) positron emission tomography (PET)/computed tomography (CT) in bladder urothelial carcinoma (UC) and an intraindividual comparison with C- choline (CHOL) PET/CT.METHODS: : Fourteen patients with biopsy-proven UC (11 T2, 3 T1 refrac
- PMID 22391726
Japanese Journal
- 膵神経内分泌腫瘍に対するneoadjuvant chemotherapy (特集 Neoadjuvant therapyの最新の動向 : がんの治療戦略はどのように変わっていくのか) -- (がん種別 : 術前補助療法の臨床的意義と今後の方向性)
- 工藤 篤,伴 大輔,上田 浩樹 [他]
- 臨床外科 = Journal of clinical surgery 70(7), 866-871, 2015-07
- NAID 40020514564
- GISTに対するneoadjuvant chemotherapy (特集 Neoadjuvant therapyの最新の動向 : がんの治療戦略はどのように変わっていくのか) -- (がん種別 : 術前補助療法の臨床的意義と今後の方向性)
- 神田 達夫,石川 卓,小杉 伸一 [他]
- 臨床外科 = Journal of clinical surgery 70(7), 860-865, 2015-07
- NAID 40020514550
- 肝細胞癌に対するneoadjuvant chemotherapy (特集 Neoadjuvant therapyの最新の動向 : がんの治療戦略はどのように変わっていくのか) -- (がん種別 : 術前補助療法の臨床的意義と今後の方向性)
- 田中 基文,福本 巧,具 英成
- 臨床外科 = Journal of clinical surgery 70(7), 838-843, 2015-07
- NAID 40020514483
Related Links
- Particularly in locally advanced tumors with high metastatic potential, neoadjuvant chemotherapy offers the possibility to treat both primary lesions and micrometastases at distant sites. ... Chemotherapy uses drugs to destroy ...
- neoadjuvant therapy listen (NEE-oh-A-joo-vant THAYR-uh-pee) Treatment given as a first step to shrink a tumor before the main treatment, which is usually surgery, is given. Examples of ...
Related Pictures
★リンクテーブル★
[★]
- 英
- neoadjuvant chemotherapy、neoadjuvant therapy
- 同
- 新補助的化学療法、術前化学療法 preoperative chemotherapy
- 関
- ネオアジュバント療法、術前化学療法、術前補助化学療法、寛解導入療法
[★]
- 英
- preoperative chemotherapy、induction chemotherapy、neoadjuvant chemotherapy
- 同
- neoadjuvant化学療法
- 関
- ネオアジュバント化学療法、導入化学療法、術前補助化学療法
[★]
- 英
- neoadjuvant chemotherapy
- 関
- ネオアジュバント化学療法、術前化学療法
[★]
- 関
- neoadjuvant chemotherapy
[★]
- 関
- ネオアジュバント化学療法、neoadjuvant chemotherapy
[★]